|
Banon R, Hernandez-Romero D, Navarro E, Perez-Carceles MD, Noguera-Velasco JA, Osuna E. Combined determination of B-type natriuretic peptide and high-sensitivity troponin I in the postmortem diagnosis of cardiac disease. Forensic Sci Med Pathol. 2019 Dec;15(4):528-535. doi: 10.1007/s12024-019-00150-1. Epub 2019 Aug 30. PubMed PMID: 31471870.
AÑO: 2019; IF: 2.456
|
31471870
|
Villalba-Lopez F, Saenz-Mateos LF, Sanchez-Lorencio MI, De La Orden-Garcia V, Alconchel-Gago F, Cascales-Campos PA, Garcia-Bernardo C, Noguera-Velasco JA, Baroja-Mazo A, Ramirez-Romero P. Usefulness of PIVKA-II for monitoring after liver transplantation in patients with hepatocellular carcinoma. Sci Rep. 2023 Apr 6;13(1):5621. doi: 10.1038/s41598-023-32879-9. PubMed PMID: 37024609; PubMed Central PMCID: PMC10079651.
AÑO: 2023; IF: 3.8
|
|
Asensio Ruiz MA, Alonso Garcia A, Bravo-Ferrer Moreno ML, Cebreiros-Lopez I, Noguera-Velasco JA, Lozano-Perez AA, Martinez Martinez T. In Vitro Hemocompatibility and Genotoxicity Evaluation of Dual-Labeled [99mTc]Tc-FITC-Silk Fibroin Nanoparticles for Biomedical Applications. Pharmaceuticals (Basel). 2023 Feb 7;16(2):248. doi: 10.3390/ph16020248. PubMed PMID: 37259395; PubMed Central PMCID: PMC9959965.
AÑO: 2023; IF: 4.3
|
|
Sanchez-Campillo M, Gazquez A, Serrano-Munuera A, Arnao MB, Aviles-Plaza F, Garcia-Serna AM, Noguera-Velasco JA, Martinez-Lopez de Castro A, Martinez-Gracia C, Suarez-Martinez C, Santaella-Pascual M, Vioque J, Montoya-Hernandez C, Ballesteros-Meseguer C, Sanchez-Ferrer M, Perez-Fernandez V, Morales E, Garcia-Marcos L, Larque E; Nela Study Group. Serum Vitamins A and E at Mid-Pregnancy and Their Relationships with Both Maternal and Cord Blood Antioxidant Status and Perinatal Conditions: The NELA Cohort. Ann Nutr Metab. 2023;79(3):313-325. doi: 10.1159/000531239. Epub 2023 Jun 2. PubMed PMID: 37271133.
AÑO: 2023; IF: 3.2
|
|
Arnaldos-Carrillo M, Noguera-Velasco JA, Martinez-Ardil IM, Riquelme-Perez A, Cebreiros-Lopez I, Hernandez-Vicente A, Ros-Lucas JA, Khan A, Bayes-Genis A, Pascual-Figal D. Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19. Med Clin (Barc). 2023 Sep 8;161(5):185-191. doi: 10.1016/j.medcli.2023.04.005. Epub 2023 Apr 11. PubMed PMID: 37137804; PubMed Central PMCID: PMC10086099.
AÑO: 2023; IF: 2.6
|